Isenberg JS - Search Results

1

Thrombospondin-1 inhibition of vascular smooth muscle cell responses occurs via modulation of both cAMP and cGMP.

Yao M, Roberts DD, Isenberg JS. Yao M, et al. Among authors: isenberg js. Pharmacol Res. 2011 Jan;63(1):13-22. doi: 10.1016/j.phrs.2010.10.014. Epub 2010 Oct 29. Pharmacol Res. 2011. PMID: 20971192 Free PMC article.

2

Thrombospondin-1/CD47 blockade following ischemia-reperfusion injury is tissue protective.

Maxhimer JB, Shih HB, Isenberg JS, Miller TW, Roberts DD. Maxhimer JB, et al. Among authors: isenberg js. Plast Reconstr Surg. 2009 Dec;124(6):1880-1889. doi: 10.1097/PRS.0b013e3181bceec3. Plast Reconstr Surg. 2009. PMID: 19952644 Free PMC article.

3

Activated CD47 regulates multiple vascular and stress responses: implications for acute kidney injury and its management.

Rogers NM, Yao M, Novelli EM, Thomson AW, Roberts DD, Isenberg JS. Rogers NM, et al. Among authors: isenberg js. Am J Physiol Renal Physiol. 2012 Oct 15;303(8):F1117-25. doi: 10.1152/ajprenal.00359.2012. Epub 2012 Aug 8. Am J Physiol Renal Physiol. 2012. PMID: 22874763 Free PMC article. Review.

4

Thrombospondin-1 regulates blood flow via CD47 receptor-mediated activation of NADPH oxidase 1.

Csányi G, Yao M, Rodríguez AI, Al Ghouleh I, Sharifi-Sanjani M, Frazziano G, Huang X, Kelley EE, Isenberg JS, Pagano PJ. Csányi G, et al. Among authors: isenberg js. Arterioscler Thromb Vasc Biol. 2012 Dec;32(12):2966-73. doi: 10.1161/ATVBAHA.112.300031. Epub 2012 Oct 18. Arterioscler Thromb Vasc Biol. 2012. PMID: 23087362 Free PMC article.

5

Age-associated induction of cell membrane CD47 limits basal and temperature-induced changes in cutaneous blood flow.

Rogers NM, Roberts DD, Isenberg JS. Rogers NM, et al. Among authors: isenberg js. Ann Surg. 2013 Jul;258(1):184-91. doi: 10.1097/SLA.0b013e31827e52e1. Ann Surg. 2013. PMID: 23275312 Free PMC article.

6

Activated CD47 promotes pulmonary arterial hypertension through targeting caveolin-1.

Bauer PM, Bauer EM, Rogers NM, Yao M, Feijoo-Cuaresma M, Pilewski JM, Champion HC, Zuckerbraun BS, Calzada MJ, Isenberg JS. Bauer PM, et al. Among authors: isenberg js. Cardiovasc Res. 2012 Mar 15;93(4):682-93. doi: 10.1093/cvr/cvr356. Epub 2012 Jan 2. Cardiovasc Res. 2012. PMID: 22215724 Free PMC article.

7

Thrombospondin-1 antagonizes nitric oxide-stimulated vascular smooth muscle cell responses.

Isenberg JS, Wink DA, Roberts DD. Isenberg JS, et al. Cardiovasc Res. 2006 Sep 1;71(4):785-93. doi: 10.1016/j.cardiores.2006.05.024. Epub 2006 May 27. Cardiovasc Res. 2006. PMID: 16820142

8

Regulation of nitric oxide signalling by thrombospondin 1: implications for anti-angiogenic therapies.

Isenberg JS, Martin-Manso G, Maxhimer JB, Roberts DD. Isenberg JS, et al. Nat Rev Cancer. 2009 Mar;9(3):182-94. doi: 10.1038/nrc2561. Epub 2009 Feb 5. Nat Rev Cancer. 2009. PMID: 19194382 Free PMC article. Review.

9

Thrombospondin-1 supports blood pressure by limiting eNOS activation and endothelial-dependent vasorelaxation.

Bauer EM, Qin Y, Miller TW, Bandle RW, Csanyi G, Pagano PJ, Bauer PM, Schnermann J, Roberts DD, Isenberg JS. Bauer EM, et al. Among authors: isenberg js. Cardiovasc Res. 2010 Dec 1;88(3):471-81. doi: 10.1093/cvr/cvq218. Epub 2010 Jul 7. Cardiovasc Res. 2010. PMID: 20610415 Free PMC article.

10

Nitric oxide and its gatekeeper thrombospondin-1 in tumor angiogenesis.

Roberts DD, Isenberg JS, Ridnour LA, Wink DA. Roberts DD, et al. Among authors: isenberg js. Clin Cancer Res. 2007 Feb 1;13(3):795-8. doi: 10.1158/1078-0432.CCR-06-1758. Clin Cancer Res. 2007. PMID: 17289869 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

189 results

Search Page

Filters